Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...
Streetwise Reports | July 2, 2020 |

Biopharma Continues 'Positive Push Forward in Breast Cancer'

The latest clinical trial results and next step are reviewed in an H.C. Wainwright & Co. report. In a Dec. 26 research note, analyst Joseph Pantginis reported that H.C. Wainwright & Co. increased its target price to AU$0.20 from AU$0.16 and maintained its Buy recommen...
Streetwise Reports | December 30, 2019 |

Eli Lilly Trades Up 15% on Positive Phase 3 Breast Cancer Trial Results

Eli Lilly shares set a new 52-week high price after the company reported that its Verzenio® (abemaciclib) significantly reduced the risk of cancer returning in people with high risk HR+, HER2- early breast cancer. Eli Lilly and Co. (LLY:NYSE) today annou...
Streetwise Reports | June 17, 2020 |

Tariffs Are Having a Bigger Effect on U.S. Manufacturing Than Initially Thought

The U.S. manufacturing sector contracted for the fifth straight month in December, with the monthly reading from the Institute for Supply Management (ISM) hitting its weakest point in more than 10 years. The purchasing manager’s index (PMI) fell to 47.2,...
Frank Holmes | January 8, 2020 |

Stumbling Manufacturing and Rising Gold – Now or Later?

American manufacturers are scoring ever deeper recessionary readings. We haven’t seen this bad an ISM Manufacturing reading in quite a while. Can it take the broader economy with it? And what about gold – when exactly will it get its shine? ISM Manufacturing...
Arkadiusz Sieron | October 3, 2019 |

Important Economic News Calendar: October 28 – November 1, 2019

Brace for a very busy week on the financial markets! The Fed will decide about the U.S. monetary policy and the Bureau of Labor Statistics will release its usually important monthly figures. Will quarterly corporate earnings push stock prices to new record highs? Let&Clos...
Paul Rejczak | October 28, 2019 |

Power of Narratives and Gold

The U.S. manufacturing sector has been growing weaker recently, entering recession. How serious is this contraction, and does it have the power to spill over to the broader economy? Let’s turn to gold – how far can these developments take us on the yellow brick...
Arkadiusz Sieron | November 22, 2019 |

GBP/USD – Pound in Holding Pattern Ahead of British GDP, Manufacturing Production

Kenny Fisher GBP/USD is showing little movement for a fifth straight day. Currently, the pair is trading at 1.3155, up 0.07% on the day. All Eyes on British GDP, Mfg. Production Investors are keeping a close eye on the monthly GDP report....
FX Empire | December 11, 2019 |

Manufacturing Goes Deeper Into Recession, Yet Gold Remains Muted. Why?

The ISM Manufacturing index fell 0.2 point to a reading of 48.1 in November. However, gold struggles to find momentum. What is going on exactly? U.S. Manufacturing Sector Slumps Further The Institute for Supply Management announced that its index of national factory a...
Arkadiusz Sieron | December 4, 2019 |

From COVID to Nicotine Treatments, this Bio Stock is One to Watch

(Image via Lexaria Bioscience Corp.) There’s no shortage of excitement over potential COVID-19 vaccines. Just looking at the response to news around these developments is evidence of that, and one Company is working on a transformative, patented tech...
Stockhouse Editorial | December 1, 2020 |
1 2 3 4 5 6 7 8 9 10 ...